|
GB0718419A
GB0718419D0
(en)
|
2007-09-20 |
2007-09-20 |
Compounds
|
|
JP2010525339A
JP2010539217A
(en)
|
2007-09-20 |
2008-09-18 |
Compounds having activity at the M1 receptor and their use as medicaments
|
|
EP08804345A
EP2194982A1
(en)
|
2007-09-20 |
2008-09-18 |
Compounds which have activity at m1 receptor and their uses in medicine
|
|
EP08804347A
EP2194983A1
(en)
|
2007-09-20 |
2008-09-18 |
Compounds which have activity at m1 receptor and their uses in medicine
|
|
PCT/EP2008/062403
WO2009037296A1
(en)
|
2007-09-20 |
2008-09-18 |
Compounds which have activity at m1 receptor and their uses in medicine
|
|
US12/678,353
US8299257B2
(en)
|
2007-09-20 |
2008-09-18 |
Compounds which have activity at M1receptor and their uses in medicine
|
|
UY31346A
UY31346A1
(en)
|
2007-09-20 |
2008-09-18 |
COMPOUNDS THAT HAVE ACTIVITY IN THE RECEIVER M1 AND ITS USES IN MEDICINE
|
|
PCT/EP2008/062400
WO2009037294A1
(en)
|
2007-09-20 |
2008-09-18 |
Compounds which have activity at m1 receptor and their uses in medicine
|
|
PE2008001632A
PE20091194A1
(en)
|
2007-09-20 |
2008-09-18 |
DERIVATIVES OF HETEROCICLICOS AS MODULATORS OF THE RECEIVER M1
|
|
ARP080104059A
AR068480A1
(en)
|
2007-09-20 |
2008-09-18 |
COMPOSITE OF 4-HETEROARIL-PIPERIDINIL-N-SUBSTITUTED ITS USE FOR THE PREPARATION OF A USEFUL MEDICINAL PRODUCT FOR THE TREATMENT OF AN AFFECTION IN WHICH THE AGONISM OF A M1 MUSCARINIC RECEIVER AND PHARMACEUTICAL COMPOSITION THAT UNDERSTAND IT
|
|
US12/678,347
US8278328B2
(en)
|
2007-09-20 |
2008-09-18 |
Compounds which have activity at M1 receptor and their uses in medicine
|
|
TW097135729A
TW200930367A
(en)
|
2007-09-20 |
2008-09-18 |
Compounds which have activity at M1 receptor and their uses in medicine
|
|
JP2010525340A
JP2010539218A
(en)
|
2007-09-20 |
2008-09-18 |
Compounds having activity at the M1 receptor and their use as medicaments
|
|
CL2008002808A
CL2008002808A1
(en)
|
2007-09-20 |
2008-09-22 |
Benzoxazole derived compounds, muscarinic m1 receptor agonists; pharmaceutical composition comprising said compounds; and use for the treatment of schizophrenia, cognitive impairment, or Alzheimer's disease.
|
|
US13/592,785
US8426443B2
(en)
|
2007-09-20 |
2012-08-23 |
Compounds which have activity at M1 receptor and their uses in medicine
|